Condition

Advanced Colorectal Cancer (Part 1)

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 2 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting0

Common interventions9

Lead sponsors shown1

Clinical trials

2 shown

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.NCT05355701 · 2022-07-05

ACTIVE_NOT_RECRUITING

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast CancerNCT00959946 · 2009-09-01

TERMINATED

Common interventions

binimetinibDRUG1 BosutinibDRUG1 CapecitabineDRUG1 cetuximabBIOLOGICAL1 fluorouracilDRUG1 leucovorinDRUG1 midazolamDRUG1 oxaliplatinDRUG1 PF-07799933DRUG1

Leading sponsors

Pfizer 2

Trial status mix

ACTIVE_NOT_RECRUITING1

TERMINATED1

Phase mix

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.